A study assessing the effects on adherence to SLE medications, HCQ alone, DMARDs combined, and MMF alone and differences between patients who did and did not benefit from the intervention
Latest Information Update: 07 Jan 2022
At a glance
- Drugs Azathioprine (Primary) ; Belimumab (Primary) ; Hydroxychloroquine (Primary) ; Leflunomide (Primary) ; Methotrexate (Primary) ; Mycophenolate mofetil (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
Most Recent Events
- 07 Jan 2022 New trial record
- 09 Nov 2021 Results presented at the ACR Convergence 2021